CLDN1 and lung adenocarcinoma: Expression of Cldn1 was demonstrated in PTC, papillary microcarcinoma primary tumors, and lymph node metastases (Nemeth et al., 2010) and is assumed to be a prognostic factor for patients with lung adenocarcinoma (Sun et al., 2016).